| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/08/2010 | EP1846373B1 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 12/08/2010 | EP1781290B1 Anti-inflammatory agents |
| 12/08/2010 | EP1771432B1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 12/08/2010 | EP1679074B1 Therapeutic agent for keratoconjunctive disorder |
| 12/08/2010 | EP1641803B3 Thienopyrimidine derivatives as potassium channel inhibitors |
| 12/08/2010 | EP1628685B1 Antiviral phosphonate analogs |
| 12/08/2010 | EP1596862B1 Use of palonosetron for treating post-operative nausea and vomiting |
| 12/08/2010 | EP1578409B1 Use of adenosine a2a receptor antagonists for treatment or prevention of extra-pyramidal syndrome |
| 12/08/2010 | EP1578351B1 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 12/08/2010 | EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 12/08/2010 | EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents |
| 12/08/2010 | EP1480674B1 Treatment of central nervous system damage |
| 12/08/2010 | EP1383487B1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 12/08/2010 | EP1321144B1 Eye drops |
| 12/08/2010 | EP1093457B1 Cytokine receptor common gamma chain like |
| 12/08/2010 | EP1007017B2 Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof |
| 12/08/2010 | EP0826041B1 Transforming growth factor alpha hii |
| 12/08/2010 | EP0772619B2 Immunomodulatory oligonucleotides |
| 12/08/2010 | CN1993113B Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof |
| 12/08/2010 | CN1990482B Flavanonol compounds and their production method and use |
| 12/08/2010 | CN1984644B Stabilised supersaturated solid solutions of steroidal drugs |
| 12/08/2010 | CN1981739B Esmolol preparation |
| 12/08/2010 | CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 12/08/2010 | CN1969992B Pharmaceutical composition for treating acne and application method thereof |
| 12/08/2010 | CN1968715B Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 12/08/2010 | CN1968704B Topical cromolyn formulations |
| 12/08/2010 | CN1965849B Composition extracted from Chinese medicinals for treating coronary heart disease and method for preparing ingredients thereof |
| 12/08/2010 | CN1964638B Synergism of GOS and polyfructose |
| 12/08/2010 | CN1960995B Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes |
| 12/08/2010 | CN1960733B Combination product comprising SRC kinase inhibitor AZD0530 and an antioestrogen or EGFR-TK-inhibitor |
| 12/08/2010 | CN1953743B Topical co-enzyme Q10 formulations and methods of use |
| 12/08/2010 | CN1950380B (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors |
| 12/08/2010 | CN1946411B Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination |
| 12/08/2010 | CN1946382B Rapid dissolution formulation of a calcium receptor-active compound |
| 12/08/2010 | CN1938034B ED-71 preparation |
| 12/08/2010 | CN1933856B Cream-gel containing ivermectin |
| 12/08/2010 | CN1929840B 8-hydroxy-5- [(-hydroxy-2- [[ (1R)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation |
| 12/08/2010 | CN1929834B Indol-1-yl-acetic acid derivatives |
| 12/08/2010 | CN1927197B Medical use of 1beta-keto-5, 11(13)-diene eudesmane-12-acid for inhibiting hepatitis B virus |
| 12/08/2010 | CN1897952B Neutrophilia inhibitor |
| 12/08/2010 | CN1882570B Quinazoline derivatives |
| 12/08/2010 | CN1864688B Agent for preventing and treating glaucoma |
| 12/08/2010 | CN1853644B Treatment and prophylaxis of diseases and infections pigs and poultry |
| 12/08/2010 | CN1850271B Medicinal composition for treating neurasthenia or somatic form disorders |
| 12/08/2010 | CN1836665B Pharmaceutical uses of hesperidin or its composition |
| 12/08/2010 | CN1829504B Amino acid composition and supplementary liquid containing the same |
| 12/08/2010 | CN1824061B Application of a combination for preparing medicine and food dual purpose nutrient for preventing true myopia |
| 12/08/2010 | CN1821243B Substituted pyridine M1 receptor excitomotor, its preparing process and its use |
| 12/08/2010 | CN1812796B Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale |
| 12/08/2010 | CN1803837B Neurotrophic growth factor |
| 12/08/2010 | CN1778294B Butin and its derivative and its use in preparation of pigmental metabolic disease medicine |
| 12/08/2010 | CN1762357B Oral medicinal formulation of moxifloxacin and its preparation method |
| 12/08/2010 | CN1759118B Diazepinoindole derivatives as kinase inhibitors |
| 12/08/2010 | CN1756527B Regulation of mammalian hair growth |
| 12/08/2010 | CN1753680B Derivatives of prostaglandins for treating abdominal discomfort |
| 12/08/2010 | CN1698611B Nanometer vauqueline liposome and preparation method thereof |
| 12/08/2010 | CN1691954B Extraction of pharmaceutically active cannabinoids from plant materials |
| 12/08/2010 | CN1679596B Dispersive composition of noncrystal Adifuwei ester and supplementary and preparation thereof |
| 12/08/2010 | CN1671696B Kinase inhibitors |
| 12/08/2010 | CN1660184B Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application |
| 12/08/2010 | CN1646174B Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 12/08/2010 | CN1620453B Thiazolidinedione derivative and its use as antidiabetic |
| 12/08/2010 | CN1594355B Cyclovirobuxinum D crystal, its mono-methanol crystal, and preparation and use thereof |
| 12/08/2010 | CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases |
| 12/08/2010 | CN1496741B Method for producing enteric nutrient containing malt ketose |
| 12/08/2010 | CN1434681B Method for maintaining or improving the synthesis of mucins |
| 12/08/2010 | CN1430513B Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia |
| 12/08/2010 | CN101910274A Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same |
| 12/08/2010 | CN101910192A 19-nor-steroid derivatives with a 15alpha,16alpha-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives |
| 12/08/2010 | CN101910191A 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid gamma-lactone derivative, use thereof, and medicament containing said derivative |
| 12/08/2010 | CN101910190A 17-hydroxy-19-nor-21-carboxylic acid-steroid gamma-lactone derivative, use thereof, and medicament containing the derivative |
| 12/08/2010 | CN101910189A Monosebacate of pyrazole derivative |
| 12/08/2010 | CN101910184A Solubilized thiazolopyridines |
| 12/08/2010 | CN101910182A Antitumor agent |
| 12/08/2010 | CN101910179A (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid |
| 12/08/2010 | CN101910177A Macrocyclic indoles as hepatitis c virus inhibitors |
| 12/08/2010 | CN101910176A Derivatives of N-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 12/08/2010 | CN101910175A N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 12/08/2010 | CN101910174A 2-benzoylimidazo[1,2-a]pyridine derivates, preparation thereof and therapeutic use thereof |
| 12/08/2010 | CN101910173A Derivatives of 2-heteroaroyl-imidazol[1,2-a] pyridine, preparation thereof and therapeutic application thereof |
| 12/08/2010 | CN101910172A Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 12/08/2010 | CN101910171A Nonsteroidal compounds useful as modulators of glucocorticoid receptor AP-1 and/or NF-kappa B activity and use thereof |
| 12/08/2010 | CN101910170A (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease |
| 12/08/2010 | CN101910169A Bicycloamine derivative |
| 12/08/2010 | CN101910168A Tropane compounds |
| 12/08/2010 | CN101910167A Heterocyclic ether and thioether derivatives and methods of use thereof |
| 12/08/2010 | CN101910166A Heterocyclic derivatives as modulators of ion channels |
| 12/08/2010 | CN101910165A Thiazole derivatives as protein kinase inhibitors |
| 12/08/2010 | CN101910164A Diamido thiazole derivatives as protein kinase inhibitors |
| 12/08/2010 | CN101910163A Heterocyclic urea and thiourea derivatives and methods of use thereof |
| 12/08/2010 | CN101910162A Cyclic pyridyl-N-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 12/08/2010 | CN101910160A Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 12/08/2010 | CN101910159A Process for production of heterocycle-substituted pyridine derivative |
| 12/08/2010 | CN101910158A Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders |
| 12/08/2010 | CN101910157A Indole compounds and methods for treating visceral pain |
| 12/08/2010 | CN101910156A Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| 12/08/2010 | CN101910155A Biphenyl derivatives as modulators of the histamine-H3 receptor useful for the treatment of disorders related thereto |
| 12/08/2010 | CN101910153A Pyrimidines as kinase inhibitors |
| 12/08/2010 | CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 12/08/2010 | CN101910151A Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119 |